GB201108272D0 - Methods relating to HCMV infected cells - Google Patents

Methods relating to HCMV infected cells

Info

Publication number
GB201108272D0
GB201108272D0 GB201108272A GB201108272A GB201108272D0 GB 201108272 D0 GB201108272 D0 GB 201108272D0 GB 201108272 A GB201108272 A GB 201108272A GB 201108272 A GB201108272 A GB 201108272A GB 201108272 D0 GB201108272 D0 GB 201108272D0
Authority
GB
United Kingdom
Prior art keywords
infected cells
hcmv
methods relating
hcmv infected
mrp
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GB201108272A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Cambridge Enterprise Ltd
Original Assignee
Cambridge Enterprise Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Cambridge Enterprise Ltd filed Critical Cambridge Enterprise Ltd
Priority to GB201108272A priority Critical patent/GB201108272D0/en
Publication of GB201108272D0 publication Critical patent/GB201108272D0/en
Priority to PCT/GB2012/051094 priority patent/WO2012156733A1/en
Ceased legal-status Critical Current

Links

Abstract

This invention relates to the identification and/or elimination of Human Cytomegalovirus (HCMV) infected cells from mammalian cell populations by determining the expression of multidrug resistance-associated protein-1 (MRP-1) and/or other UL138 modulated cell surface proteins. HCMV infected cells may be identified through alterations in the expression MRP-1 and/or other UL138 modulated cell surface proteins, and separated. Mammalian cell populations depleted of HCMV infected cells may be useful, for example in transplants, such as bone marrow transplants.
GB201108272A 2011-05-17 2011-05-17 Methods relating to HCMV infected cells Ceased GB201108272D0 (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB201108272A GB201108272D0 (en) 2011-05-17 2011-05-17 Methods relating to HCMV infected cells
PCT/GB2012/051094 WO2012156733A1 (en) 2011-05-17 2012-05-16 Detection and depletion of hcmv infected cells

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB201108272A GB201108272D0 (en) 2011-05-17 2011-05-17 Methods relating to HCMV infected cells

Publications (1)

Publication Number Publication Date
GB201108272D0 true GB201108272D0 (en) 2011-06-29

Family

ID=44260678

Family Applications (1)

Application Number Title Priority Date Filing Date
GB201108272A Ceased GB201108272D0 (en) 2011-05-17 2011-05-17 Methods relating to HCMV infected cells

Country Status (2)

Country Link
GB (1) GB201108272D0 (en)
WO (1) WO2012156733A1 (en)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP2886552A1 (en) * 2013-12-17 2015-06-24 Ecole Polytechnique Federale de Lausanne (EPFL) Methods for purging isolated organs and cells from latent human cytomegalovirus
CN107817340A (en) * 2017-08-01 2018-03-20 东南大学 A kind of kit of SERS technology for detection Mdr-p and its application

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9015198D0 (en) 1990-07-10 1990-08-29 Brien Caroline J O Binding substance
US5783383A (en) * 1995-05-23 1998-07-21 The Board Of Trustees Of The Leland Stanford Junior University Method of detecting cytomegalovirus (CMV)
AU783502B2 (en) * 1999-11-24 2005-11-03 Oklahoma Medical Research Foundation Assays and therapies for latent viral infection
WO2002059142A2 (en) * 2001-01-26 2002-08-01 Epidauros Biotechnologies Ag Polymorphisms in the human gene for the multidrug resistance-associated protein 1 (mrp-1) and their use in diagnostic and therapeutic applications
AU2002242086A1 (en) * 2001-02-02 2002-08-19 Chemocentryx, Inc. Chemomagnetic retrieval of cmv and cmv infected cells
US20100151441A1 (en) * 2005-09-23 2010-06-17 The Trustees Of Princeton University Human Cytomegalovirus Latency Promoting Genes, Related Virus Variants and Methods of Use

Also Published As

Publication number Publication date
WO2012156733A1 (en) 2012-11-22

Similar Documents

Publication Publication Date Title
MX2013003681A (en) Engineered nucleic acids and methods of use thereof.
MX2012011779A (en) 5-position modified pyrimidines and their use.
GEP201706605B (en) Antibodies for epidermal growth factor receptor 3 (her3)
EP2547346A4 (en) System for purifying certain cell populations in blood or bone marrow by depleting others
MX351659B (en) Non-aqueous high concentration reduced viscosity suspension formulations of antibodies.
IN2014DN07531A (en)
EA201491837A1 (en) CHEMICAL ANTIGENOUS RECEPTORS AIMED AT ANTIGEN OF B-CELL MATURATION
MX2015005675A (en) Compositions and methods for modulating cell signaling.
WO2012019103A8 (en) System and apparatus for cell treatment
MA38632B1 (en) Anti-transferrin receptor antibodies and methods of use
CA2806858C (en) Reprogramming immortalized b cells
AR090973A1 (en) USEFUL ANTIBODIES FOR CANCER DIAGNOSIS
EA201692359A1 (en) COMPOSITION BASED ON NEW PRRSV STRAIN OR HIS PROTEINS, PRODUCT, THEIR USE, PRRSV VIRUS, ISOLATED NK AND A RECOMBINANT VECTOR OF EXPRESSION FOR OBTAINING THIS VIRUS
GB201020995D0 (en) Biological materials and uses thereof
NZ586576A (en) Improved mammalian expression vectors and uses thereof
EA201590247A1 (en) ANTIBODIES TO SIGLEC-15
GB2513768A (en) Complexes of cytomegalovirus proteins
AR093446A1 (en) ANTIHEMAGLUTININE ANTIBODIES AND METHODS OF USE
EP4297036A3 (en) Method for predicting the off-target binding of a peptide which binds to a target peptide presented by a major histocompatibility complex
WO2013014294A3 (en) Improved baculovirus expression systems
WO2011021194A3 (en) Pericyte progenitor cells and methods of generating and using same
MX363493B (en) Cell culture compositions and methods for polypeptide production.
EA201491144A1 (en) METHOD OF FLOCULATION
EP3107995A4 (en) Biophysically sorted osteoprogenitors from culture expanded bone marrow derived mesenchymal stromal cells (mscs)
MX2015000754A (en) Human btnl3 proteins, nucleic acids, and antibodies and uses thereof.

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)